| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.005 |